Functional epitope mapping of human interleukin-1β by surface plasmon resonance

European Cytokine Network

Volumn 8, Issue 2, 1997, Pages 161-171

  D'Ettorre, Cinzia ^a   De Chiara, Giovanna ^b   Casadei, Rossella ^a   Boraschi, Diana ^a   Tagliabue, Aldo ^a  

^a Chemistry Section   (Italy)

^b Consorzio NIRECO ^*  (Italy)

Author keywords

Antibodies; Cytokine receptors; Cytokines; Surface plasmon resonance

Indexed keywords

CYTOKINE ANTIBODY; EPITOPE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; EPITOPE MAPPING; HUMAN; KINETICS; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; BINDING SITES; BIOSENSING TECHNIQUES; EPITOPE MAPPING; EPITOPES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; KINETICS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEINS; RECEPTORS, INTERLEUKIN-1; THERMODYNAMICS;

EID: 0031412632     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Dinarello C A. 1989. Interleukin-1 and its biologically related cytokines. (Review) Adv. Immunol. 44: 153.
2. Dinarello C A. 1996. Biological basis for interleukin-1 in disease. (Review) Blood 87: 2095.
3. Arend W P. 1991. Interleukin-1 receptor antagonist. A new member of the interleukin-1 family. (Review) J. Clin. Invest. 88: 1445.
4. Boraschi D, Tagliabue A. 1989. Structure-function relationship of interleukin-1 giving new insights for its therapeutic potential. (Review) Biotherapy 1: 377.
5. Antoni G, Presentini R, Perin F, Tagliabue A, Ghiara P, Censini S, Volpini G, Villa L, Boraschi D. 1986. A short synthetic-fragment of human interleukin-1 with immunostimulatory but not inflammatory activity. J. Immunol. 137: 3201.
6. Mac Donald H R, Wingfield P, Schmeissner U, Shaw A, Clore G M, Gronenborn A M. 1986. Point mutations of human interleukin-1 with decreased receptor binding affinity. FEBS Lett. 209: 295.
7. 1H-NMR study of human interleukin-1β. Sequence specifity assignment of aromatic residues using site-directed mutant proteins. Eur. J. Biochem. 161: 37.
8. Huang J J, Newton R C, Horuk R, Matthew J B, Covington M, Pezzella K, Lin Y A. 1987. Muteins of human interleukin-1 that show enhanced bioactivity. FEBS Lett. 223: 294.
9. Kamogashira T, Sakaguchi M, Ohmoto Y, Mizuno K, Shimizu R, Nagamura K, Nakai S, Masui Y, Mirai Y 1988. Site-specific mutagenesis of the human interleukin-1β gene: the role of arginine residue at the N-terminal region. J. Biochem. (Tokyo) 104: 837.
10. Kamogashira T, Masui Y, Ohmoto Y, Hirato T, Nagamura K, Mizuno K, Hong Y M, Kikumoto Y, Nakai S, Mirai Y 1988. Site specific mutagenesis of the human interleukin-1β gene: structure-function analysis of the cysteine residues. Biochem. Biophys. Res. Commun. 150: 1106.
11. Boraschi D, Nencioni L, Villa L, Censini S, Bossu P, Ghiara P, Presentini R, Perin F, Frasca D, Doria G, Forni G, Musso T, Giovarelli M, Ghezzi P, Bertini R, Besedovski H O, del Rey A, Sipe J D, Antoni G, Silvestri S, Tagliabue A. 1988. In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin-1β. J. Exp. Med. 168: 675.
12. Finzel B C, Clancy L L, Holland D R, Muchmore S W, Watenpaugh K D, Einsphar H M. 1989. Crystal structure of recombinant human interleukin-1β at 2.0 Å resolution. J. Mol. Biol. 209: 779.
13. Tagliabue A, Antoni G, Boraschi D. 1989. Defining agonist peptides of human interleukin-1β. Lymphokine Res. 8: 311.
14. Boraschi D, Antoni G, Perin F, Villa L, Nencioni L, Ghiaru P, Presentini R, Tagliabue A. 1990. Defining the structural requirements of biologically active domain of IL-1β. Eur. Cytokine Netw. 1: 21.
15. Nakai S, Kawai K, Hirai Y, Tasaka K. 1990. A mutant protein of human interleukin-1β with immunostimulatory but not pyrogenic potency. Life Sci. 47: 1707.
16. Naito Y, Fukata J, Masui Y, Hirai Y, Murakami N, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H. 1990. Interleukin-1β analogues with markedly reduced pyrogenic activity can stimulate secretion of adrenocorticotropic hormone in rats. Biochem. Biophys. Res. Commun. 167: 103.
17. Gehrke L, Jobling S A, Paik L S, McDonald B, Rosenwasser L J, Auron P F. 1990. A point mutation uncouples human interleukin-1β biological activity and receptor binding. J. Biol. Chem. 265: 5922.
18. Obal F Jr, Opp M, Cady A B, Johannsen L, Postlethwaite A E, Poppleton H M, Seyer J M, Krueger J M. 1990. Interleukin-1α and interleukin-1β fragment are somnogenic. Am. J. Physiol. 259: R439.
19. Folliard F, Touchet N, Terlain B. 1990. Comparison of the binding of IL-1 mutants on lymphocytes and chondrocytes and their effects on some biological activites. Discovery of an IL-1β mutant with dissociated properties. J. Leuk. Biol. S1: 51.
20. Clore G M, Wingfield P T, Gronenborn A M. 1990. High resolution three-dimensional structure of interleukin-1β in solution by three and four-dimensional nuclear magnetic resonance spectroscopy. Biochemistry 30: 2315.
21. Conca W, Auron P E, Aoun-Wathne M, Bennett N, Seckinger P, Welgus H G, Goldring S R, Eisenberg S P, Dayer J M, Krane S M, Gehrke L. 1991. An interleukin-1β point mutant demostrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expression. J. Biol. Client. 266: 16265.
22. Tale S, Kikumoto Y, Ichikawa S, Kaneko M, Masui Y, Kamogashira T, Ouchi M, Takahashi S, Inagaki F. 1992. Stable isotope aided nuclear magnetic resonance study to investigate the receptor-binding site of human interleukin-1β. Biochemistry 31: 2435.
23. Chang J Y, Nagai P K, Priestle J P, Joss U, Vosbeck K D, van Oostrum J. 1992. Identification of a reactive lysyl residue (Lys 103) of recombinant human interleukin-1β. Mechanism of its reactivity and implication of its functional role in receptor binding. Biochemistry 31: 2874.
24. Auron P E, Quigley G J, Rosenwasser L J, Gehrke L. 1992. Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1β protein. Biochemistry 31: 6632.
25. Veerapandian B, Gilliland G L, Raag R, Svensson A L, Masui Y, Hirai Y, Poulos T L. 1992. Functional implications of interleukin-1β based on the three-dimensional structure. (Review) Proteins 12: 10.
26. Camacho N P, Smith D R, Goldman A, Schneider B, Green D, Young P R, Berman H M. 1993. Structure of an interleukin-1β mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition. Biochemistry 32: 8749.
27. Palla E, Bensi G, Solito E, Buonamassa D T, Fassina G, Raugei G, Spano F, Galeotti C, Mora M, Domenighini M, Ros- sini M, Gallo E, Carinci V, Bugnoli M, Bertini F, Parente L, Melli M. 1993. Loop substitution as a tool to identity active sites of interleukin-1β. J. Biol. Chem. 268: 13486.
28. Grütier M G, van Oostrum J, Priestle J P, Edelmann E, Joss U, Feige U, Vosbeck K, Schmitz A. 1994. A mutational analysis of receptor binding sites of interleukin-1β differences in binding of human interleukin-1β muteins to human and mouse receptors. Protein Eng. 7: 663.
29. Simoncsits A, Bristulf J, Tjörnhammar M L, Cserzo M, Pongor S, Rybakina E, Gatti S, Bartfai T. 1994. Deletion mutants of human interleukin-1β with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin-1 receptors. Cytokine 6: 206.
30. Boraschi D, Bossù P, Ruggiero P, Tagliabue A, Bertini R, Macchia G, Gasbarro C, Pellegrini L, Melillo G, Ulisse E, Visconti U, Bizzarri C, Del Grosso E, Mackay A R, Frascotti G, Frigerio F, Grifantini R, Grandi G. 1995. Mapping of receptor binding sites on IL-1β by reconstruction of IL-1ra like domains. J. Immunol. 155: 4719.
31. Massone A, Baldari C, Censini S, Bartalini M, Nucci D, Boraschi D, Telford J L. 1988. Mapping of biological revelant sites on human IL-1β using monoclonal antibodies. J. Immunol. 140: 3812.
32. Bigio M, Rossi R, Borri M G, Casagli M C, Nucci D, Baldari C, Volpini G, Boraschi D. 1989. One-step immunoaffinity purification of bioactive human recombinant IL-1β with a monoclonal antibody directed to a well-exposed domain of the protein. J. Immunol. Meth. 123: 1.
33. Boraschi D, Volpini G, Villa L, Nencioni L, Scapigliati G, Nucci D, Antoni G, Matteucci G, Cioli F, Tagliabue A. 1989. A monoclonal antibody to the IL-1β peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1β in vivo. J. Immunol. 143: 131.
34. Boraschi D, Villa L, Ghiara P, Presentini R, Bossù P, Censini S, Nucci D, Massone A, Rossi R, Flad H D, Tagliabue A. 1991. Differential inhibition of IL-1β activities and receptor binding by monoclonal antibodies mapping within a discrete region of the protein. Lymphokine Cytokine Res. 10: 377.
35. Simon P L, Kumar V, Lillquist J S, Bhatnagar P, Einstein R, Lee J, Porter T, Green D, Sathe G, Young P R. 1993. Mapping of neutralizing epitopes and the receptor binding site of human interleukin-1β. J. Biol. Chem. 268: 9771.
36. Jönsson U, Fägerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K. Lötås S, Persson B, Roos H, Rönnberg I, Sjölander S, Stenberg E, Ståhlberg R, Urbaniczky C, Östlin H, Malmqvist M. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and sensor chip technology. Biotechniques 11: 620.
37. Bellini A V, Galli G, Fascetti E, Frascotti G, Branduzzi P, Lucchese G, Grandi G. 1991. Production processes of recombinant IL-1β from Bacillus subtilis: comparision between intracellular and exocellular expression. J. Biotechnol. 18: 177.
38. Baldari C, Murray J A, Ghiara P, Cesareni G, Galeotti C L. 1987. A novel leader peptide which allows efficient secretion of a fragment of human interleukin-1β in Saccharomyces cerevisiae. EMBO J. 6: 229.
39. Stenberg E, Persson B, Roos H, Urbaniczky C. 1991. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid Interface Sci. 143: 513.
40. Johnsson B, Löfås S, Lindquist G. 1991. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198: 268.
41. Karlsson R, Michaelsson A, Mattsson L. 1991. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Meth. 145: 229.
42. Karlsson R, Roos H, Bigio M, Fägerstam L, Persson B. 1994. Kinetic and concentration analysis using BIA technology. Methods 6: 99.
43. Casagli M C, Borri M G, Bigio M, Rossi R, Nucci D, Bossù P, Boraschi D, Antoni G. 1989. Different conformation of a purified human recombinant interleukin-1βfrom Escherichia coli and Saccharomyces cerevisiae is related to different level of biological activity. Biochem. Biophys. Res. Commun. 162: 357.
44. Pucci P, Siciliano R, Ferranti P, Malorni A, Marino G. 1990. Mass spectrometric characterization of recombinant human interleukin-1β. Biotechnol. Appl. Biochem. 12: 357.
45. Labriola-Tompkins E, Chandran C, Kaffka K L, Biondi D, Graves B J, Hatada M, Madison V S, Karas J, Kilian P L, Ju G. 1991. Identification of the discontinuous binding site in human interleukin-1β for the type I interleukin-1 receptor. Proc. Natl. Acad. Sci. USA 88: 11182.
46. Evans R J, Bray J, Childs J D, Vigers G P A, Brandhuber B J, Skalicky J J, Thompson R C, Eisenberg S E. 1995. Mapping receptor binding sites in interleukin-(IL)-1 receptor antagonist and IL-1β by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1β. J. Biol. Chem. 270: 11477.
47. Ju G, Labriola-Tompkins E, Campen C A, Benjamin W R, Karas J, Plocinski J, Biondi D, Kaffka K L, Kilian P L, Eisenberg S P, Evans R J. 1991. Conversion of interleukin-1 receptor antagonist into an agonist by site-specific mutagenesis. Proc. Natl. Acad. Sci. USA 88: 2658.
48. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R A, Ju G. 1995. Molecular cloning and characterization of second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270: 13757.
49. Greenfeder S A, Varnell T, Powers G, Lombard-Gillooly K, Shuster D, McIntyre K W, Ryan D E, Levin W, Madison V, Ju G. 1995. Insertion of a structural domain of interleukin-(IL)-1β confers agonistic activity to the IL-1 receptor antagonist. J. Biol. Chem. 270: 22460.
50. Boraschi D, Ghiara P, Scapigliati G, Villa L, Sette A, Tagliabue A. 1992. Binding and internalization of the 163-171 fragment of human IL-1β. Cytokine 4: 201.